PSCA (gene)

Revision as of 13:36, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Prostate stem cell antigen
Identifiers
Symbols PSCA ; PRO232
External IDs Template:OMIM5 Template:MGI HomoloGene: 4150
RNA expression pattern
File:PBB GE PSCA 205319 at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Prostate stem cell antigen, also known as PSCA, is a human gene.[1]

This gene encodes a glycosylphosphatidylinositol-anchored cell membrane glycoprotein. In addition to being highly expressed in the prostate it is also expressed in the bladder, placenta, colon, kidney, and stomach. This gene is up-regulated in a large proportion of prostate cancers and is also detected in cancers of the bladder and pancreas. This gene has a nonsynonymous nucleotide polymorphism at its start codon.[1]

References

  1. ↑ 1.0 1.1 "Entrez Gene: PSCA prostate stem cell antigen".

Further reading

  • Reiter RE, Gu Z, Watabe T; et al. (1998). "Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer". Proc. Natl. Acad. Sci. U.S.A. 95 (4): 1735–40. PMID 9465086.
  • Gu Z, Thomas G, Yamashiro J; et al. (2000). "Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer". Oncogene. 19 (10): 1288–96. doi:10.1038/sj.onc.1203426. PMID 10713670.
  • Bahrenberg G, Brauers A, Joost HG, Jakse G (2000). "Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors". Biochem. Biophys. Res. Commun. 275 (3): 783–8. doi:10.1006/bbrc.2000.3393. PMID 10973799.
  • Amara N, Palapattu GS, Schrage M; et al. (2001). "Prostate stem cell antigen is overexpressed in human transitional cell carcinoma". Cancer Res. 61 (12): 4660–5. PMID 11406532.
  • Watabe T, Lin M, Ide H; et al. (2002). "Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter". Proc. Natl. Acad. Sci. U.S.A. 99 (1): 401–6. doi:10.1073/pnas.012574899. PMID 11752398.
  • Ross S, Spencer SD, Holcomb I; et al. (2002). "Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate". Cancer Res. 62 (9): 2546–53. PMID 11980648.
  • Jain A, Lam A, Vivanco I; et al. (2003). "Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene". Mol. Endocrinol. 16 (10): 2323–37. PMID 12351697.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Tran CP, Lin C, Yamashiro J, Reiter RE (2003). "Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells". Mol. Cancer Res. 1 (2): 113–21. PMID 12496358.
  • Clark HF, Gurney AL, Abaya E; et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMID 12975309.
  • Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
  • Zhang Z, Henzel WJ (2005). "Signal peptide prediction based on analysis of experimentally verified cleavage sites". Protein Sci. 13 (10): 2819–24. doi:10.1110/ps.04682504. PMID 15340161.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Fraga MF, Ballestar E, Villar-Garea A; et al. (2005). "Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer". Nat. Genet. 37 (4): 391–400. doi:10.1038/ng1531. PMID 15765097.
  • Lam JS, Yamashiro J, Shintaku IP; et al. (2005). "Prostate stem cell antigen is overexpressed in prostate cancer metastases". Clin. Cancer Res. 11 (7): 2591–6. doi:10.1158/1078-0432.CCR-04-1842. PMID 15814638.
  • Zhigang Z, Wenlu S (2006). "Complete androgen ablation suppresses prostate stem cell antigen (PSCA) mRNA expression in human prostate carcinoma". Prostate. 65 (4): 299–305. doi:10.1002/pros.20290. PMID 16015594.
  • Wente MN, Jain A, Kono E; et al. (2006). "Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer". Pancreas. 31 (2): 119–25. PMID 16024997.
  • Oh JH, Yang JO, Hahn Y; et al. (2006). "Transcriptome analysis of human gastric cancer". Mamm. Genome. 16 (12): 942–54. doi:10.1007/s00335-005-0075-2. PMID 16341674.
  • Grubbs EG, Abdel-Wahab Z, Tyler DS, Pruitt SK (2007). "Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer". Ann. Surg. Oncol. 13 (12): 1645–54. doi:10.1245/s10434-006-9029-5. PMID 16957968.
  • Morgenroth A, Cartellieri M, Schmitz M; et al. (2007). "Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells". Prostate. 67 (10): 1121–31. doi:10.1002/pros.20608. PMID 17492652.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=PSCA_(gene)&oldid=723365"